Sign in
TerminatedNo phase

Early IntraVenous Administration of Nutritional Support

Key facts

Who runs it
Fondazione IRCCS Policlinico San Matteo di Pavia
Where
Italy1 site in 1 countryChoose a country to see its locations
Trial code
Status
Terminated
People taking part
34 people enrolled
Started
14 Apr 2020
Ended
30 Jul 2024
Type of study
Interventional, 2 groups
Treatments tested
  • Nutritional counseling alone
  • Early supplemental parenteral nutrition plus nutritional counseling
Record updated
7 May 2025
Why it stopped
Changes in anticancer treatment protocols which limit recruitment

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Cannot take part
Show the full registry criteria (18)Hide the full registry criteria

Who can take part

  • histologically confirmed diagnosis of metastatic gastric and gastroesophageal cancer
  • no previous chemotherapy for metastatic disease
  • indication for a first-line chemotherapy with a combination of 2 drugs including platinum derivatives (plus Trastuzumab if HER2+) to be used by investigator's choice within the framework of good clinical practice and in agreement with current Italian Association of Medical Oncology guidelines
  • measurable disease based on Response Evaluation Criteria in Solid Tumors (RECIST)
  • presence of nutritional risk (Nutritional Risk Screening 2002 score ≥3)
  • availability of permanent venous access (Port, Groshong, PICC)
  • Eastern Cooperative Oncology Group (ECOG) performance status ≤2
  • availability of a home parenteral nutrition service to continue nutritional plan as scheduled
  • signed informed consent

Who cannot take part

  • contraindication to parenteral nutrition (abnormal glucose and electrolytes control, hyper-triglyceridemia, impaired hemodynamic control and fluid retention)
  • age <18 years
  • ECOG performance status >2
  • indication to complete artificial nutrition support (totally compromised spontaneous food-intake)
  • availability of jejunostomy for nutritional purposes
  • ongoing home artificial nutrition
  • unfeasible home parenteral nutrition for social/familial reasons
  • absence of caregivers
  • patients refusal

Where is this trial?

It has locations in one country. Choose a country to see its locations.

What happens in this trial

What the trial wants to find out

The present trial will be conducted to verify if early supplemental parenteral nutrition in combination with nutritional counseling improves survival and the feasibility of chemotherapy, in addition to nutritional status, body composition, functional status and quality of life in treatment-naïve patients with metastatic gastric cancer at nutritional risk undergoing first-line chemotherapy.

The 2 groups in the trial

  • Nutritional counseling aloneOther group

    Nutritional counseling consists of a personalized dietary prescription with regular consultation by a registered dietitian and telephone interviews, as well as of the use of oral nutritional supplements, when necessary.

  • Supplemental parenteral nutrition plus nutritional counselingTreatment being tested

    Patients will receive nutritional counseling in combination with systematic early supplemental home parenteral nutrition since diagnosis.

    Treatment: Early supplemental parenteral nutrition plus nutritional counseling

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Early IntraVenous Administration of Nutritional Support (IVANS) in Metastatic Gastric, Cancer Patients at Nutritional Risk Undergoing First-line Chemotherapy
Publications
Record updated
7 May 2025